Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DTC Risk Information Placement Can Affect Fair Balance, Academic Tells FDA

Executive Summary

Direct-to-consumer ads need to better reflect the effect of risk information placement on patient comprehension of a drug's risk-benefit profile, a Duke University professor told FDA during a public meeting on DTC advertising in Washington, D.C. Sept. 22

You may also be interested in...



Pfizer DTC Comments Prescribe Limited Risk Info, Reliance On Physicians

Risk information in direct-to-consumer ads should be designed to prompt more patient-physician dialogue, Pfizer suggested in comments to FDA

Pfizer DTC Comments Prescribe Limited Risk Info, Reliance On Physicians

Risk information in direct-to-consumer ads should be designed to prompt more patient-physician dialogue, Pfizer suggested in comments to FDA

FDA Invites Manufacturers, Ad Agencies To Discuss DTC Ad Designs

FDA would like to consult with pharmaceutical companies and their advertising agencies early on in the development of direct-to-consumer advertising campaigns

UsernamePublicRestriction

Register

LL1135645

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel